(lp0
S'Biotech Quick Pick: Insys Therapeutics Seeking Alpha - Mar 13, 2017 To determine if Insys Therapeutics is a long or short opportunity we will first translate the current stock price into a series of assumptions the market seems to be making about the future of the company. As evidenced by a 98% decline from highs ...Insys Therapeutics Inc  Set to Announce Earnings on Thursday - Chaffey BreezeRecent Update on Price Movements: Insys Therapeutics, Inc.  - Is stories'
p1
aS'Insys Therapeutics Announces Delay in the Release of its Fourth Quarter and ... GlobeNewswire  - Mar 15, 2017 PHOENIX, March 15, 2017  -- Insys Therapeutics, Inc.   today announced that the Company will delay the release of its financial results for the fourth quarter and full year 2016.Stock Returns: INSYS Therapeutics Inc  versus MacroGenics Inc ... - CML NewsInsys Therapeutics, Inc.  Files An 8-K Results of Operations and ... - Market Exclusive'
p2
aS"Glancy Prongay &amp; Murray LLP Commences Investigation on Behalf of Insys ... Yahoo Finance - Mar 16, 2017 Glancy Prongay &amp; Murray LLP  is investigating potential claims on behalf of investors of Insys Therapeutics, Inc.   concerning the Company and its officers' possible violations of federal securities laws."
p3
aS'SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of ... PR Newswire  - Mar 16, 2017 NEW YORK, March 16, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of INSYS Therapeutics, Inc.  . Such investors are advised to contact Robert S. Willoughby at&nbsp;...'
p4
aS'Insys Therapeutics to Report Fourth Quarter and Full Year 2016 Results GlobeNewswire  - Feb 15, 2017 PHOENIX, March 02, 2017  -- Insys Therapeutics, Inc.   today announced that the Company will release its financial results for the fourth quarter and full year 2016 on Thursday, March 16, 2017,&nbsp;...'
p5
aS'SHAREHOLDER ALERT: Bronstein, Gewirtz &amp; Grossman, LLC Announces Investigation ... Yahoo Finance - Mar 16, 2017 NEW YORK, March 16, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz &amp; Grossman, LLC is investigating potential claims on behalf of purchasers of the INSYS Therapeutics, Inc.  . Such investors are advised&nbsp;...'
p6
aS"Insys Therapeutics Inc  Might Be A Discount At Current Prices Insider Financial - Feb 22, 2017 Throughout December last year, Insys Therapeutics Inc  flat lined around $9 a share. Despite continued effort by management to maintain a positive news flow, and in turn, to buoy positive sentiment, the company couldn't break the $10 a&nbsp;...Insys Therapeutics Inc.  Plunges 5.04% on February 23 - Equities.comEarnings Guidance on Insys Therapeutics, Inc. - Energy Index"
p7
aS'EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims ... Business Wire  - Mar 16, 2017 NEW YORK----Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Insys Therapeutics, Inc.  resulting from allegations that Insys may have&nbsp;...IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Insys ... - Yahoo Finance'
p8
aS'EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action ... Yahoo Finance - 18 hours ago Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Insys Therapeutics, Inc. securities  from February 23, 2016 through March 15, 2017, inclusive . The ...'
p9
aS'Pomerantz Law Firm Announces the Filing of a Class Action against INSYS ... Yahoo Finance - 23 hours ago NEW YORK, March 17, 2017  -- Pomerantz LLP announces that a class action lawsuit has been filed against INSYS Therapeutics, Inc.   and certain of its officers. The class action, filed in United States&nbsp;...'
p10
a.